Meta-analysis of the association between new hypoglycemic agents and digestive diseases

New hypoglycemic agents include sodium-glucose cotransporter-2 inhibitors (SGLT2is), glucagon-like peptide 1 receptor agonists (GLP1RAs), and dipeptidyl peptidase-4 inhibitors (DPP4is). The association between each class of these new hypoglycemic drugs and the risks of various digestive system disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu-Wen, Lin, Jin-Hao, Yang, Cui-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410596/
https://www.ncbi.nlm.nih.gov/pubmed/36042668
http://dx.doi.org/10.1097/MD.0000000000030072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410596/
https://www.ncbi.nlm.nih.gov/pubmed/36042668
http://dx.doi.org/10.1097/MD.0000000000030072

Ejemplares similares